GlassScriptPhysician profile
Justin Van Hoorebeke
NPI 1013476183
$5,724.67
in general payments reported to CMS, 2019-2025
13 companies · $2,774 in 2025
The $2,774 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $156 · 2024: $2,795 · 2025: $2,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,057 · Travel and Lodging: $2,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,056.58 |
| Travel and Lodging | $2,512.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,564.80 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $1,233.65 | 2024 | |
| Davol INC. | $946.94 | 2024-2025 | Phasix Mesh |
| Axogen | $588.07 | 2025 | Axoguard Ha+ Nerve Protector |
| Kerecis Limited | $252.18 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Urgo Medical North America, LLC | $240.66 | 2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Acera Surgical, INC. | $213.96 | 2025 | Restrata Wound Matrix |
| Innovation Technologies INC | $170.15 | 2024 | Irrisept |
| Intuitive Surgical, INC. | $155.69 | 2022 | |
| Vioptix INC | $153.14 | 2024 | T. Ox Tissue Oximeter |
| Access Pro Medical, LLC | $142.75 | 2025 | Matriderm |
| Ethicon US, LLC | $38.43 | 2025 | Stratafix |
| Depuy Synthes Sales INC. | $24.25 | 2025 | Matrixrib |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Van Hoorebeke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.